Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors

Pediatric Blood and Cancer - United States
doi 10.1002/pbc.21873
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase II Study of SU5416, a Small Molecule Vascular Endothelial Growth Factor Tyrosine Kinase Receptor Inhibitor, in Patients With Refractory Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2004English

A Phase I Study of Foretinib, a Multi-Targeted Inhibitor of C-Met and Vascular Endothelial Growth Factor Receptor 2

Clinical Cancer Research
Cancer ResearchOncology
2010English

Expression of the Vascular Endothelial Growth Factor C Receptor VEGFR-3 in Lymphatic Endothelium of the Skin and in Vascular Tumors

American Journal of Pathology
Forensic MedicinePathology
1998English

Vascular Endothelial Growth Factor-C and Its Receptor VEGFR-3 in the Nasal Mucosa and in Nasopharyngeal Tumors

American Journal of Pathology
Forensic MedicinePathology
2000English

Tumors of the Pediatric Central Nervous System

Journal of Neuro-Ophthalmology
MedicineOphthalmologyNeurology
2013English

Vascular Endothelial Growth Factor Receptor Inhibitor SU5416 Suppresses Lymphocyte Generation and Immune Responses in Mice by Increasing Plasma Corticosterone

PLoS ONE
Multidisciplinary
2013English

Morphological Spectrum of Pediatric Central Nervous System Tumors- A Seven Year Study From Central India

Journal of Medical Science And clinical Research
2019English

Liquid Biopsy for Pediatric Central Nervous System Tumors

npj Precision Oncology
2018English

Nephrotic Syndrome Unfavorable Course Correlates With Downregulation of Podocyte Vascular Endothelial Growth Factor Receptor (VEGFR)-2

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy